| Issue |
J Extra Corpor Technol
Volume 46, Number 4, December 2014
|
|
|---|---|---|
| Page(s) | 317 - 323 | |
| DOI | https://doi.org/10.1051/ject/201446317 | |
| Published online | 15 December 2014 | |
Technique Article
Use of del Nido Cardioplegia for Adult Cardiac Surgery at the Cleveland Clinic: Perfusion Implications
* Perfusion Services, Cleveland Clinic, Cleveland, Ohio
† Heart and Vascular Institute, Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio
Address correspondence to: Kuna Kim, BS, Clinical Research Coordinator, Perfusion Services, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195. E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Received:
27
July
2014
Accepted:
21
October
2014
Abstract
Cardiac arrest by cardioplegia provides a reproducible and safe method to induce and maintain electromechanical cardiac quiescence. Techniques of intraoperative myocardial protection are constantly evolving. For the past three decades, modified Buckberg cardioplegia solution has been used for adult cardiac surgery at the Cleveland Clinic. This formulation serves as the crystalloid component, which is delivered 4:1 with oxygenated patient’s blood to crystalloid. Meanwhile, our use of the del Nido cardioplegia solution in adult patients, heretofore primarily used in pediatric cardiac surgical centers, has been increasing over the past several years. Single-dose, cold blood del Nido cardioplegia can be delivered antegrade if the duration of the operation will be limited and if there is no significant coronary artery disease or aortic insufficiency that would limit the distribution of cardioplegia. The addition of del Nido cardioplegia to our cardioplegia armamentarium allows us to customize our myocardial protection strategies for different surgical needs. This article aims to provide information on technical aspects of del Nido cardioplegia in adult cardiac surgery and its use at the Cleveland Clinic in the adult surgical population.
Key words: myocardial protection and cardioplegia / del Nido solution
The senior author has stated that the authors have reported no material, financial, or other relationship with any healthcare-related business or other entity whose products or services are discussed in this paper.
© 2014 AMSECT
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.
